Skip to main content

FAM172A Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84900

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-84900-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the middle region of Human FAM172A. Peptide sequence: SSDSSDEPAEKRERKDKVSKETKKRRDFYEKYRNPQREKEMMQLYIRENG The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for FAM172A Antibody

Western Blot: FAM172A Antibody [NBP2-84900]

Western Blot: FAM172A Antibody [NBP2-84900]

Western Blot: FAM172A Antibody [NBP2-84900] - Host: Rabbit. Target Name: FAM172A. Sample Type: Fetal Kidney lysates. Antibody Dilution: 1.0ug/ml

Applications for FAM172A Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: FAM172A

Alternate Names

C5orf21, chromosome 5 open reading frame 21, DKFZP564D172, family with sequence similarity 172, member A, hypothetical protein LOC83989

Gene Symbol

FAM172A

Additional FAM172A Products

Product Documents for FAM172A Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for FAM172A Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...